179 related articles for article (PubMed ID: 11035916)
1. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
Centurion SA; Kuo HR; Lambert WC
Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
[TBL] [Abstract][Full Text] [Related]
2. Arrest of S-phase progression is impaired in Fanconi anemia cells.
Sala-Trepat M; Rouillard D; Escarceller M; Laquerbe A; Moustacchi E; Papadopoulo D
Exp Cell Res; 2000 Nov; 260(2):208-15. PubMed ID: 11035915
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
4. 3R coordination by Fanconi anemia proteins.
Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
[TBL] [Abstract][Full Text] [Related]
5. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
[TBL] [Abstract][Full Text] [Related]
6. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase.
Akkari YM; Bateman RL; Reifsteck CA; D'Andrea AD; Olson SB; Grompe M
Mol Genet Metab; 2001 Dec; 74(4):403-12. PubMed ID: 11749045
[TBL] [Abstract][Full Text] [Related]
7. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
9. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome.
Ridet A; Guillouf C; Duchaud E; Cundari E; Fiore M; Moustacchi E; Rosselli F
Cancer Res; 1997 May; 57(9):1722-30. PubMed ID: 9135015
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
11. Interaction of FANCD2 and NBS1 in the DNA damage response.
Nakanishi K; Taniguchi T; Ranganathan V; New HV; Moreau LA; Stotsky M; Mathew CG; Kastan MB; Weaver DT; D'Andrea AD
Nat Cell Biol; 2002 Dec; 4(12):913-20. PubMed ID: 12447395
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells.
Kumaresan KR; Sridharan DM; McMahon LW; Lambert MW
Biochemistry; 2007 Dec; 46(50):14359-68. PubMed ID: 18020456
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer for the eventual treatment of Fanconi's anemia.
Liu JM
Semin Hematol; 1998 Apr; 35(2):168-79. PubMed ID: 9565158
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
15. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for fanconi anemia.
Croop JM
Curr Hematol Rep; 2003 Jul; 2(4):335-40. PubMed ID: 12901331
[TBL] [Abstract][Full Text] [Related]
17. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
18. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
[TBL] [Abstract][Full Text] [Related]
19. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
[TBL] [Abstract][Full Text] [Related]
20. Identification of Alu-mediated deletions in the Fanconi anemia gene FAA.
Levran O; Doggett NA; Auerbach AD
Hum Mutat; 1998; 12(3):145-52. PubMed ID: 9711872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
